MXLSX | VISVX | MXLSX / VISVX | |
Total Expense Ratio | 1.09 | 0.19 | 574% |
Annual Report Gross Expense Ratio | 1.15 | 0.19 | 605% |
Fund Existence | 31 years | 27 years | - |
Gain YTD | 3.720 | 6.264 | 59% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 601M | 59.2B | 1% |
Annual Yield % from dividends | 0.00 | 1.86 | - |
Returns for 1 year | 5.42 | 8.05 | 67% |
Returns for 3 years | 31.21 | 36.32 | 86% |
Returns for 5 years | 77.46 | 85.77 | 90% |
Returns for 10 years | 79.28 | 117.41 | 68% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MSFU | 52.09 | 1.08 | +2.12% |
Direxion Daily MSFT Bull 2X Shares | |||
CPSR | 24.75 | 0.02 | +0.07% |
Calamos S&P 500 Structured Alt Protection ETF - March | |||
RDVY | 66.27 | -0.05 | -0.08% |
First Trust Rising Dividend Achiev ETF | |||
IBBQ | 23.71 | -0.13 | -0.53% |
Invesco Nasdaq Biotechnology ETF | |||
THQ | 17.02 | -0.12 | -0.70% |
abrdn Healthcare Opportunities Fund |